Diagnosis and the importance of early treatment of tyrosinemia type 1: A case report.
Clin Mass Spectrom
; 12: 1-6, 2019 Apr.
Article
en En
| MEDLINE
| ID: mdl-34841073
BSTFA+1%TCMS, N,O-Bis (trimethylsilyl)trifluoroacetamide with 1% trimethylchlorosilane 99:1; CE, collision energy; CXP, collision cell exit potential; DBS, dried blood spot; DP, declustering potential; EP, entrance potential; ESI, electrospray ionization; FAA, fumarylacetoacetate; FAH, fumarylacetoacetate hydrolase; GC MS, capillary gas chromatography coupled with mass spectrometry; GS1, nebulizer gas; GS2, heater gas; HCl, hydrochloric acid; LC-MS/MS, tandem mass spectrometry coupled with ultra performance liquid chromatography; MRM, multiple reaction monitoring; NBS, newborn screening; NTBC, 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione; PFBO, O-(2,3,4,5,6-Pentafluorobenzyl)hydroxylamine hydrochloride; Q1, first quadrupole; Q3, third quadrupole; RCF, Relative Centrifugal Force; RP, reverse phase; SUAC, succinylacetone; TIC, Total Ion Chromatogram; TYRSN1, tyrosinemia type 1; Tyr, tyrosine; Tyr_IS, tyrosine internal standard
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Tipo de estudio:
Diagnostic_studies
Idioma:
En
Revista:
Clin Mass Spectrom
Año:
2019
Tipo del documento:
Article
País de afiliación:
Croacia
Pais de publicación:
Países Bajos